If there is any information that you would like included on this page please contact Alexandra Fullem (alexfullem@gmail.com). The website is updated approximately twice a month.
PDP Press Releases/ statements
• 5 Jun: HIV vaccine research funding faces an uncertain future
• 12 May: Strengthening regional R&D: Integrated Dengue control in urban Malaysia
• 23 Apr: Afrigen Biologics and Vaccines: A Catalyst in mRNA Technology and LMIC Capacity Strengthening
• 24 Apr: Price of Key DR-TB Medicine Drops 25% as TB Alliance’s Multi-Manufacturer Strategy Expands Access
• 17 Jun: New global collaboration launched to tackle antimicrobial resistance through improved diagnostics
• 26 Jun: Dapivirine vaginal ring recommended as an HIV prevention option for adolescent girls
• 27 Jun: A shot of hope: How the malaria vaccine is helping to change lives in Kenya
• 6 Jun: MMV appoints Executive Vice President of External Affairs
• 10 Jun: MMV’s scientific advisor appointed Director General of African Medicines Agency
• 27 Jun: MMV 2024 Annual Report
• 1 Jul: Thailand’s Government Pharmaceutical Organization (GPO) partners with DNDi and Pharco to register an effective and affordable hepatitis C treatment
• 5 Jun: Meet the DNDi Eastern Africa 2024-2025 Media Fellows
• 13 Jun: K-MEDI and DNDi have initiated collaborative R&D to develop a treatment for neglected diseases
• 13 Jun: Serum Institute of India signs a memorandum of understanding (MoU) with DNDi to advance the development of a new treatment for dengue in low- and middle-income countries
• 2 Jul: FIND Board Chair Dr Ayoade Alakija Appointed Ministerial Global Envoy for Antimicrobial Resistance
• 15 Jun: IVI and KDCA co-host 2025 Global Vaccine Forum on next-generation platforms for rapid development and pandemic response
• 7 Apr: EVI initiates a new clinical trial to protect pregnant women against malaria
• 14 Apr: EVI to support GAVI's malaria learning agenda
MDGH
• 20 Feb: U.S. FDA expands indication for moxidectin to treat river blindness in children as young as four
PDP Funder News/Announcements
• 2 Jul: Commission launches new strategy to make Europe a global leader in life sciences by 2030. European Commission
• 9 Jun: Notice of GHIT Board Member Changes. GHIT
• 11 Jun: Unitaid supports uptake of objective blood loss measurement devices to advance lifesaving care for postpartum hemorrhage in resource-limited settings. Unitaid
• 12 Jun: Executive board affirms Unitaid’s vision for a changing global health landscape. Unitaid
• 17 Jun: Unitaid accelerates push to eliminate cervical cancer by 2030 with US$50 million commitment over two years to improve access to screening and treatment. Unitaid
• 18 Jun: Unitaid welcomes U.S. FDA approval of lenacapavir and calls for urgent action on affordability and access. Unitaid
• 24 Jun: “We must rethink how we work”: New Unitaid report showcases how innovation and access strategies can support stronger country-led health systems. Unitaid
• 24 Jun: Child Deaths Will Rise if Funding for Lifesaving Vaccine Program Falters. Gates Foundation
• 25 Jun: GHIT Annual Report 2024. GHIT
• 25 Jun: UK partners with Gavi to help save up to 8 million lives by 2030. UK Government
• 27 Jun: EDCTP Forum: from Kigali to Madrid. EDCTP
Funder Announcement Archives
• 2014 PDP Funder Announcements
• 2013 PDP Funder Announcements
New PDP Publications
• 25 Apr: Rethinking antibodies for infectious diseases?. IAVI
Other Reports/ Publications
• 12 May: Securing Britain’s Future: How Investments in Ending Malaria Strengthen the UK Economy, Life Sciences Sector and NHS. Malaria No More UK
Related Press Releases/ Announcements/Articles
• 1 Jul: Obama and Bush call Trump’s USAID closure a ‘travesty’ as report warns of 14 million extra deaths. The Guardian
• 1 Jul: EXCLUSIVE: WHO Chief Names New Team of Directors – Mostly Familiar Faces. Health Policy Watch
• 1 Jul: Targeting RAP proteins for next-generation malaria treatments. News Medical
• 1 Jul: Safety and immunogenicity of investigational tuberculosis vaccine M72/AS01E–4 in people living with HIV in South Africa: an observer-blinded, randomised, controlled, phase 2 trial. The Lancet HIV
• 1 Jul: USAID cuts could lead to 14 million deaths over the next five years, researchers say. NBC News
• 1 Jul: Insufficient testing allows Sierra Leone’s mpox outbreak to surge. Nature Africa
• 1 Jul: Six things you need to know about how vaccines fight antimicrobial resistance. Gavi
• 2 Jul: RFK Jr.’s intellectually dishonest excuse for defunding Gavi, the Vaccine Alliance. STAT
• 2 Jul: Can health survive the development finance revolution?. Devex
• 2 Jul: Gavi’s Sania Nishtar is ‘very hopeful’ US will return as a donor. Devex
• 2 Jul: U.S. Retreat From Global Vaccine May Increase Diseases, Experts Warn. Forbes
• 2 Jul: USAID Formally Shut Down – Days After Scientists Warn Closure Will Kill 2.4 Million People Every Year. Health Policy Watch
• 2 Jul: As mosquito season peaks, officials brace for new normal of dengue cases. News Medical
• 3 Jul: Undoing progress through sudden tuberculosis funding cuts. The Lancet
• 3 Jul: The investment shift that could reshape African health care. Devex
• 3 Jul: NIH restores grants to South Africa scientists, adds funding option for other halted foreign projects. Science
• 3 Jun: A reset of international development for the UK requires a principles-based approach. BMJ
• 2 Jul: Leadership change at African journal sparks calls for bold reform. Nature
• 3 Jun: The Pandemic Agreement is a milestone: now it is time for action in national capitals. The Lancet
• 3 Jun: Is dengue becoming endemic in Europe?. Gavi
• 3 Jun: New mRNA vaccine is more effective and less costly to develop, study finds. MedicalXpress
• 3 Jun: Report highlights evidence, remaining data gaps on vaccines and antibiotic resistance. CIDRAP
• 3 Jun: Substandard and falsified antibiotics are associated with antimicrobial resistance: a retrospective country-level analysis. BMJ
• 4 Jun: Trump Budget Eliminates Funding for Crucial Global Vaccination Programs. The New York Times
• 4 Jun: The Gavi Leap: radical transformation for a new global health architecture. The Lancet
• 4 Jun: Trump budget request and rescission plan slashes global health funding. Devex
• 4 Jun: Current state and future directions of interventions for neglected tropical diseases. Nature
• 4 Jun: Cepheid HIV viral load test receives Health Canada license. 360Dx
• 5 Jun: Scientists devise plan to curb fatalities from deadly superbugs: 'One of the most pressing global health and development challenges of our time'. The Cool Down
• 5 Jun: Breakthrough in search for HIV cure leaves researchers ‘overwhelmed’. The Guardian
• 5 Jun: Preparing for Disease X in a Changing World. The Scientist
• 5 Jul: Mpox in DR Congo: a call to action. The Lancet
• 5 Jun: 'Neglected tropical diseases' now face even more neglect. NPR
• 5 Jun: AVAC Denounces White House Effort to Codify DOGE Cuts to Health, Research and Foreign Assistance. AVAC
• 5 Jun: Reimagining Antimicrobial Resistance (AMR) financing for Africa amid global funding crises. PLOS
• 5 Jun: Antibodies Remain 6 Months After Chikungunya Vaccine Administered in Youngest Children. Contagion Live
• 6 Jun: Sierra Leone battles intense mpox activity as Ethiopia reports first death. CIDRAP
• 6 Jun: Analysis shows mpox lurked in Nigeria for 8 years before igniting global 2022 outbreak. CIDRAP
• 6 Jun: Role of malaria exposure and off-target responses on RTS,S/AS02A vaccine immunogenicity and protection in Mozambican children. Nature
• 6 Jun: WHO Releases Bibliography on Antimicrobial Resistance: A Vital Tool in a Global Health Battle. TWN
• 6 Jun: mRNA HIV vaccine shows promise in proof-of-concept clinical trials. Tides Global
• 6 Jun: Skyrocketing mpox outbreak in Sierra Leone raises fears of wider spread. Nature
• 6 Jun: Study finds non-prescription antibiotic use high in young children in poorer countries. CIDRAP
• 6 Jun: The potential role of AI in research priority setting exercises. The Journal of Global Health
• 8 Jun: Cuts to UK’s global vaccination funding would risk avoidable child deaths, experts warn. The Guardian
• 9 Jun: Oxford vaccine against deadly Nipah virus granted European Medicines Agency PRIME designation. University of Oxford
• 9 Jun: ‘We Dissent’: NIH Staff Hit Out Against ‘Politicised’ Research. Health Policy Watch
• 9 Jun: Rethinking regulation to face future pandemic threats. CEPI
• 9 Jun: Money Matters: How Open Society Foundations funds in the global south. Devex
• 9 Jun: Special edition: Germany steps into the void USAID left behind. Devex
• 9 Jun: WHO extends mpox emergency for African surge. CIDRAP
• 9 Jun: Mpox Vaccine Manufacturer’s Excessive Price, Trump Administration Cuts Compromise Access. Public Citizen
• 9 Jun: WHO: Call for benefit sharing from Mpox and COVID-19 pathogens and sequence data use. TWN
• 9 Jun: NIH terminates network aimed at stopping pandemics before they start. Science
• 10 Jun: WHO, UNAIDS Urge Pakistan to Locally Produce HIV and TB Drugs After Indian Supply Disruption. TB CAB
• 10 Jun: Global burden of chikungunya virus infections and the potential benefit of vaccination campaigns. Nature
• 10 Jun: Key biological markers in severe malaria could pave path for future treatments. MedicalXpress
• 10 Jun: Oxford taps CDMO Recipharm to handle additional manufacturing work in malaria vaccine collab. Fierce Pharma
• 10 Jun: US aid cuts threaten South Africa’s status as powerhouse of HIV and tuberculosis research. The Telegraph
• 11 Jun: US foreign aid cuts threaten decades of progress on driving down malaria. CNN
• 11 Jun: Getting PrEP Rollout Right This Time. AVAC
• 11 Jun: WHO target product profile for TB detection at peripheral settings: 2024 update. PLOS
• 11 Jun: Reimagining HIV prevention with artificial intelligence. Lancet HIV
• 11 Jun: Vaccine group Gavi seeks to broaden donor base as aid budgets shrink. Reuters
• 11 Jun: 5 ways Gavi has saved lives through innovative finance – and there’s more to come. Gavi
• 11 Jun: Trump administration to cut all USAID overseas roles in dramatic restructuring. The Guardian
• 11 Jun: Chikungunya vaccine could stop millions of infections worldwide, study finds. News Medical
• 12 Jun: PrEP in 2025: Bridging the gap between innovation and access. Jhpeigo
• 12 Jun: Europe–Africa collaboration: working together to strengthen health research, implementation, and equitable systems. The Lancet
• 12 Jun: Tackling the scourge of malaria drug resistance. The Guardian Nigeria
• 12 Jun: GSK licenses Shigella vaccine candidate to Bharat Biotech for continued development. GSK
• 12 Jun: Gavi and Asian Development Bank sign new partnership to boost health financing for immunisation. Gavi
• 12 Jun: Charting the Fallout of Aid Cuts. CGD
• 12 Jun: The Front Lines of Tuberculosis Vaccine Research. The Medicine Maker
• 12 Jun: Stop TB Partnership retains US funds but must revise scope, cut staff. Devex
• 12 Jun: USAID’s Role in Global Health Supply Chain Programs and Implications of Aid Cuts: A Rapid Review. CGD
• 12 Jun: Stop TB Partnership retains US funds but must revise scope, cut staff. Devex
• 13 Jun: Mpox Vaccine Manufacturer Urged to Drop Price Amid Huge Shortfall in Africa. Health Policy Watch
• 13 Jun: First Newborn Recruited for New Sepsis Study. Health Policy Watch
• 13 Jun: Global action urgently needed to tackle antimicrobial resistance, experts warn. Phys.org
• 13 Jun: How the malaria vaccine came to the world’s most mosquito-bitten district. Gavi
• 13 Jun: Congress shows first signs of resisting Trump’s plans to slash science budgets. Science
• 13 Jun: Strategies for shortening tuberculosis therapy. Nature Medicine
• 16 Jun: Hundreds of NIH grant terminations are ‘void and illegal,’ federal judge rules. STAT
• 16 Jun: Why Africa’s path to vaccine self-reliance is tough but necessary. The East African
• 16 Jun: Merck Launches Phase 3 Trial of Single-Dose Dengue Vaccine Candidate V181. Contagion Live
• 16 Jun: A Stronger Path Forward for Infection Control and Antimicrobial Resistance: Learning From COVID-19. The Record
• 16 Jun: Paper-based devices show high accuracy in detecting asymptomatic malaria. News Medical
• 16 Jun: Strengthening National Regulatory Authorities in Africa: A Critical Step Towards Enhancing Local Manufacturing of Vaccines and Health Products. MDPI
• 16 Jun: Private equity firm will finance Harvard research lab, in possible template for future. STAT
• 17 Jun: Vector-borne helminthiases: a road map for current and future research to support control and elimination in sub-Saharan Africa. The Lancet Infectious Diseases
• 17 Jun: Q&A: Aid cuts call for African self-reliance in research. SciDevNet
• 17 Jun: Opinion: In science’s new era, open and transparent cooperation remains key. Nature
• 17 Jun: South Africa Built a Medical Research Powerhouse. Trump Cuts Have Demolished It. The New York Times
• 17 Jun: R21/Matrix-M Malaria Vaccine Drives Diverse Immune Responses in Pre-Exposed Adults: Insights from a Phase IIb Controlled Human Malaria Infection Trial. Frontiers
• 17 Jun: The Gavi replenishment – a turning point for funding health multilaterals?. BOND
• 17 Jun: ‘HIV-ending’ drug could be made for just $25 per patient a year, say researchers. The Guardian
• 17 Jun: Lymphatic filariasis: from neglected tropical disease to national priority. The Lancet Infectious Diseases
• 18 Jun: Lenacapavir-associated drug resistance: implications for scaling up long-acting HIV pre-exposure prophylaxis. The Lancet HIV
• 18 Jun: HIV protection with just two shots a year: FDA approves Gilead drug. STAT
• 18 Jun: FDA approves new HIV prevention tool, though access questions linger. Devex
• 18 Jun: Ending TB in the spotlight in landmark BRICS Health Ministers’ declaration. WHO
• 18 Jun: No, South Africa’s HIV care is not ‘under control’. To pretend so recalls the dark days of Aids denialism. The Guardian
• 18 Jun: Treatment outcomes of bedaquiline-resistant tuberculosis: a retrospective and matched cohort study. The Lancet Infectious Diseases
• 18 Jun: Unified global action needed to tackle bedaquiline-resistant tuberculosis. The Lancet Infectious Diseases
• 18 Jun: US accused of denying R&D grants for biotechs based on international investor links. Fierce Biotech
• 18 Jun: Bavarian Nordic sells FDA priority review voucher from chikungunya vaccine approval for $160M. Fierce Pharma
• 19 Jun: Nigerian company to make HIV, malaria test kits after US funding cut. Reuters
• 19 Jun: New dual-adjuvant vaccine strategy offers hope in the fight against HIV. News Medical
• 19 Jun: Pioneering research to develop all-in-one vaccine against some of the world’s most deadly diseases. CEPI
• 20 Jun: More than 13mn people in Africa could catch malaria owing to proposed US cuts. Financial Times
• 20 Jun: New ways to tackle antimicrobial resistance. European Pharmaceutical Manufacturer
• 21 Jun: Estimating the potential malaria morbidity and mortality avertable by the US President's Malaria Initiative in 2025: a geospatial modelling analysis. The Lancet
• 21 Jun: Reinforcing resilience: confronting the consequences of global malaria aid cuts in Africa. The Lancet
• 21 Jun: Africa's role in the WHO Pandemic Agreement. The Lancet
• 21 Jun: The mpox response: African leadership, global responsibility. The Lancet
• 21 Jun: Trump aid cuts deal a blow to HIV prevention in Africa. Reuters
• 22 Jun: Here Is All the Science at Risk in Trump’s Clash With Harvard. The New York Times
• 23 Jun: Developing globally-accessible medicines for pandemic preparedness: An analysis of three alternative innovation models. Global Public Health
• 23 Jun: Japan has more than doubled its foreign aid budget in just five years. Our World in Data
• 23 Jun: Will Gates and other funders save massive public health database at risk from Trump cuts?. Nature
• 23 Jun: $9 Billion, 500 Million Children, $250 Billion ROI: Why Gavi's Brussels Summit Matters. Gavi
• 23 Jun: Opinion: If Gavi plans a ‘sunset,’ let it be a thoughtful transition. Devex
• 23 Jun: Malaria Vaccines Free Up Clinics to Improve Child Health in Cameroon. Medium
• 24 Jun: The Drug That Could Revolutionize the Fight Against H.I.V. The New Yorker
• 24 Jun: Norway Reaffirms Health Leadership with First Public Pledge to Global Fund’s 2025 Replenishment. The Global Fund
• 24 Jun: Malaria protein plays dual role in immune evasion and activation. News Medical
• 24 Jun: Gates Foundation to commit $1.6 billion for Gavi vaccine alliance. Reuters
• 24 Jun: Balancing promise and peril: risk management in India's BPaL introduction. The Lancet
• 24 Jun: Norway puts brakes on Gavi pledge, old promises strain the budget. Development Today
• 24 Jun: US scientific leadership faces uncertain future amid HHS overhaul. GHTC
• 24 Jun: Agile policies for antimicrobial resistance: A contextual approach to sustainable health challenges. Global Public Health
• 24 Jun: Blended Finance Won’t Save Global Health – Renewed Public Sector Commitment Might. Geneva Health Files
• 24 Jun: Can monoclonal antibodies effectively treat malaria? Scientists say the answer is a resounding 'yes'. MedicalXpress
• 24 Jun: Bill Gates says he will not fill vaccine funding gap left by aid cuts. Financial Times
• 24 Jun: The future of global health is innovation. Global Health Insights
• 24 Jun: Trinity Biotech nabs WHO approval for outsourced manufacturing of rapid HIV test. 360Dx
• 24 Jun: Antimicrobial resistance in Africa: A retrospective analysis of data from 14 countries, 2016–2019. PLOS Medicine
• 24 Jun: Financing Health Innovation in Africa. Think Global Health
• 25 Jun: Gavi Seeks Support Amid Global Vaccination Backsliding. Health Policy Watch
• 25 Jun: Germany pledges 600 million euros to vaccine group Gavi. Reuters
• 25 Jun: Opinion: 5 realities and 5 opportunities for global health financing. Devex
• 25 Jun: Price of world’s first malaria vaccine (RTS,S) for children in endemic countries to be reduced by more than half, to less than $5. GSK
• 25 Jun: Africa launches landmark consortium to transform health research with longitudinal data. Centre for Tropical Medicine and Global Health
• 25 Jun: RFK Jr. says US won’t donate to global vaccine effort. Politico
• 25 Jun: Promise of Victory Over H.I.V. Fades as U.S. Withdraws Support. The New York Times
• 25 Jun: Canada renews support to protect the world’s children against infectious diseases. Global Affairs Canada
• 25 Jun: Gavi Statment. Gavi
• 25 Jun: US to stop financial support of global vaccine alliance Gavi, health secretary. Reuters
• 25 Jun: Kennedy Withdraws U.S. Funding Pledge to International Vaccine Agency. The New York Times
• 25 Jun: Grand Challenges Canada to Anchor Gavi's Innovation Fund to Scale Immunization Solutions. The Globe & Mail
• 25 Jun: Price of first malaria vaccine to be slashed by more than half. Devex
• 25 Jun: Gavi pledges fall short about $2.9B as US pulls out. Devex
• 25 Jun: The Cruel Irony of Prevention. AVAC
• 25 Jun: Fostering better science by releasing biomedical research and innovation from the grip of rich nations. PLOS Global Public Health
• 25 Jun: Gavi statement on the global health architecture. Gavi
• 25 Jun: GAVI Vaccine Alliance Secures Whopping $9 Billion from Donors – Despite US Ambush at Pledging Event. Health Policy Watch
• 25 Jun: UK pledge to global vaccine effort falls £400m to £1.25bn amid raft of aid cuts. The Independent
• 25 Jun: NIH halts grant terminations ‘effective immediately,’ email says. STAT
• 25 Jun: Novel mRNA technology coaxes HIV out of hiding. POZ
• 25 Jun: CIDRZ administers first dose in groundbreaking shigella vaccine trial. Centre for Infectious Disease Research Zambia
• 25 Jun: Britain slashes global vaccine budget, putting millions of women and girls at risk. The Telegraph
• 25 Jun: World leaders recommit to immunisation amid global funding shortfall. Gavi
• 25 Jun: First all-oral treatment for deadly strain of sleeping sickness now available in Africa. Nature
• 26 Jun: ‘Single shot’ malaria vaccine delivery system could transform global immunisation. University of Oxford
• 26 Jun: Devex CheckUp: Gavi falls around $2.9 billion short. Devex
• 26 Jun: Spain's aid budget is rising — but has a long way to go. Devex
• 26 Jun: Tailored TB treatment based on disease severity may improve patient outcomes. MedicalXpress
• 26 Jun: Trial of Jynneos mpox vaccine begins in infants, toddlers, pregnant women. CIDRAP
• 26 Jun: New technology brings antibiotic resistance surveillance to the field. CIDRAP
• 26 Jun: Private sector, philanthropy can’t replace Trump administration science cuts. STAT
• 26 Jun: Gavi secures record number of pledges: now the hard work of immunising the world’s children begins. Gavi
• 26 Jun: Africa Unites to Take Stock of Disease Burden and Financial Needs towards NTDs Elimination by 2030. Africa CDC
• 27 Jun: How cuts to Gavi reflect US disengagement from development. Devex
• 27 Jun: CEPI appoints Executive Director of People and Organisation. CEPI
• 27 Jun: New credit card-sized TB test could close the diagnostic gap in HIV hotspots. MedicalXpress
• 27 Jun: The participation of people deprived of liberty in tuberculosis vaccine trials: should they be protected from research, or through research?. The Lancet
• 28 Jun: Lenacapavir approved for HIV but draws ire over cost. The Lancet
• 28 Jun: Luke O’Neill: New HIV jab raises hope of a world without Aids. The Irish Independent
• 30 Jun: Evaluating the impact of two decades of USAID interventions and projecting the effects of defunding on mortality up to 2030: a retrospective impact evaluation and forecasting analysis. The Lancet
• 30 Jun: Tracking maturity of the enabling environment for clinical trials. The Lancet
Upcoming Meetings/ Webinars
--------------------------